AbbVie Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A whale has taken a bearish stance on AbbVie (NYSE:ABBV), with 53% of detected unusual options trades being bearish. Whales have been targeting a price range of $110 to $155 for AbbVie over the last 3 months. The stock is currently down 1.55% at $142.65, and RSI indicators suggest it may be oversold. Guggenheim, Wells Fargo, and Morgan Stanley maintain Buy, Overweight, and Overweight ratings on AbbVie, with price targets of $171, $195, and $182, respectively.
May 23, 2023 | 7:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AbbVie experiences unusual options activity with a bearish stance from a whale. The stock is down 1.55% at $142.65, and RSI indicators suggest it may be oversold. Analysts maintain positive ratings with price targets ranging from $171 to $195.
The bearish stance from a whale in the options market may have a short-term negative impact on AbbVie's stock price. The stock is currently down and RSI indicators suggest it may be oversold. However, analysts maintain positive ratings and higher price targets, which could provide some support for the stock in the longer term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100